Cerus (CERS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
22 Apr, 2026Executive summary
Annual meeting scheduled for June 2, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of two directors, William M. Greenman and Ann Lucena, to serve until the 2029 annual meeting.
Approval of an amendment and restatement of the 2024 Equity Incentive Plan, increasing authorized shares by 10 million and making additional changes.
Advisory vote on executive compensation for named executive officers.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director nominees and plan amendments.
Latest events from Cerus
- Record revenue growth and global expansion driven by INTERCEPT blood safety technologies.CERS
Corporate presentation22 Apr 2026 - Proxy covers director elections, equity plan expansion, pay, auditor, and governance highlights.CERS
Proxy filing22 Apr 2026 - Record 2025 growth and global expansion highlight strong momentum in blood safety innovation.CERS
Corporate presentation9 Mar 2026 - Double-digit growth driven by U.S. and global expansion, new products, and strong partnerships.CERS
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - 2025 revenue hit $233.8M with narrowing losses and strong IFC and INT200-driven growth.CERS
Q4 20252 Mar 2026 - Q2 product revenue up 16%, net loss narrowed, and 2024 guidance raised to $175–178M.CERS
Q2 20242 Feb 2026 - BARDA awards up to $248M for U.S. program; Europe plans new submission after CE Mark setback.CERS
Study Update19 Jan 2026 - Q3 2024 revenue up 16%, net loss narrowed, and full-year guidance raised on strong demand.CERS
Q3 202417 Jan 2026 - Global expansion, product innovation, and operational leverage drive strong growth outlook.CERS
Stifel 2024 Healthcare Conference13 Jan 2026